A COAGULATION ANOMALY: PLASMA BEING MADE NON-CLOTTABLE BY ADDING THROMBIN, AND CLOTTABLE BY THROMBOPLASTIN-CALCIUM OR TOLUIDINE BLUE-THROMBIN.V5 BLUE-THROMBIN.
D000037:Abruptio Placentae; D000347:Afibrinogenemia; D000614:Aminocaproates; D015119:Aminocaproic Acid; D001780:Blood Coagulation Tests; D001803:Blood Transfusion; D002118:Calcium; D003907:Dexamethasone; D004358:Drug Therapy; D005260:Female; D005313:Fetal Death; D005340:Fibrinogen; D005341:Fibrinolysin; D006474:Hemorrhagic Disorders; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D013917:Thrombin; D013925:Thromboplastin; D014048:Tolonium Chloride; D014592:Uterine Hemorrhage
D000614:Aminocaproates; D014048:Tolonium Chloride; D003907:Dexamethasone; D005340:Fibrinogen; D013925:Thromboplastin; D013917:Thrombin; D005341:Fibrinolysin; D002118:Calcium; D015119:Aminocaproic Acid
ABRUPTIO PLACENTAE; AFIBRINOGENEMIA; AMINOCAPROIC ACID; BLOOD COAGULATION TESTS; BLOOD TRANSFUSION; DEXAMETHASONE; DRUG THERAPY; FETAL DEATH; FIBRINOGEN; FIBRINOLYSIN; HEMORRHAGIC DIATHESIS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBIN; THROMBOPLASTIN; UTERINE HEMORRHAGE